missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ IFT88 Polyclonal Antibody

Description
This antibody is predicted to react with canine and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 128,000.
This gene encodes a member of the tetratrico peptide repeat family. Mutations of a similar gene in mouse can cause polycystic kidney disease. Two transcript variants encoding distinct isoforms have been identified for this gene.
Specifications
Specifications
| Antigen | IFT88 |
| Applications | Western Blot, Immunocytochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 |
| Gene | IFT88 |
| Gene Accession No. | Q13099, Q61371 |
| Gene Alias | AW552028; D13S1056E; DAF19; fb37b11; flexo; fxo; HGNC:20606; hTg737; Ift88; intraflagellar transport 88; intraflagellar transport 88 homolog; intraflagellar transport protein; intraflagellar transport protein 88; intraflagellar transport protein 88 homolog; MGC26259; orpk; osm-5; oval; ovl; polaris; polaris homolog; polaris; axonemal transport protein; probe hTg737 (polycystic kidney disease, autosomal recessive); recessive polycystic kidney disease protein Tg737; Recessive polycystic kidney disease protein Tg737 homolog; RP11-172H24.2; testicular tissue protein Li 93; tetratricopeptide repeat domain 10; tetratricopeptide repeat protein 10; TG737; Tg737 protein; Tg737Rpw; TgN(Imorpk)737Rpw; TgN737Rpw; TPR repeat protein 10; transgene insert site 737, insertional mutation, polycystic kidney disease; Ttc10; wu:fb37b11; xx:zah8127 |
| Gene Symbols | IFT88 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?